|
|
|
Insider
Information: |
Rowinsky Eric K |
Relationship: |
Director |
City: |
Branchburg |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
589,560 |
|
Indirect Shares
|
2,000 |
|
|
Direct
Value |
$6,599,033 |
|
|
Indirect Value
|
$7,360 |
|
|
Total
Shares |
591,560 |
|
|
Total
Value |
$6,606,393 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
5
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
2
|
5
|
|
|
|
Gain/Loss Ratio : |
-2.0
|
-5.0
|
Percentage
Gain/Loss : |
-31.9%
|
-94.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biogen Idec Inc |
BIIB |
Director |
2024-02-15 |
20,629 |
2010-03-22 |
0 |
Premium* |
|
Navidea Biopharmaceuticals |
NAVB |
Director |
2018-02-20 |
341,446 |
2011-08-19 |
0 |
Premium* |
|
Stemline Therapeutics Inc |
STML |
Chief Medical Officer |
2015-04-27 |
143,688 |
2013-04-24 |
0 |
Premium* |
|
Fortress Biotech, Inc. |
FBIO |
Director |
2024-01-01 |
68,797 |
2014-02-20 |
0 |
Premium* |
|
DNIB Upwind Inc |
BIND |
Director |
2016-08-29 |
15,000 |
2016-08-29 |
0 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2017-09-05 |
0 |
2017-09-05 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NAVB |
Navidea Biopharmaceutical... |
Director |
|
2011-08-19 |
4 |
B |
$2.55 |
$38,250 |
D/D |
15,000 |
15,000 |
2.39 |
- |
|
FBIO |
Fortress Biotech, Inc. |
Director |
|
2021-03-02 |
4 |
S |
$4.45 |
$44,500 |
D/D |
(10,000) |
720,000 |
0 |
% |
|
BIIB |
Biogen Idec Inc |
Director |
|
2024-02-15 |
4 |
B |
$222.54 |
$101,256 |
D/D |
455 |
20,629 |
2.39 |
% |
|
BIIB |
Biogen Idec Inc |
Director |
|
2015-03-19 |
4 |
OE |
$59.82 |
$139,560 |
D/D |
2,333 |
13,643 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Medical Officer |
|
2014-04-25 |
4 |
S |
$15.01 |
$168,004 |
D/D |
(11,179) |
131,773 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Medical Officer |
|
2015-04-27 |
4 |
S |
$15.77 |
$170,694 |
D/D |
(10,824) |
143,688 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Medical Officer |
|
2013-08-01 |
4 |
D |
$27.88 |
$188,051 |
D/D |
(6,745) |
143,869 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2015-03-09 |
4 |
OE |
$59.82 |
$279,120 |
D/D |
4,666 |
15,976 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2015-03-17 |
4 |
OE |
$59.82 |
$279,180 |
D/D |
4,667 |
15,977 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Medical Officer |
|
2013-11-25 |
4 |
S |
$20.56 |
$285,846 |
D/D |
(13,903) |
128,966 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2014-01-21 |
4 |
AS |
$310.09 |
$626,382 |
D/D |
(2,020) |
10,440 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2015-03-20 |
4 |
OE |
$59.82 |
$697,920 |
D/D |
11,667 |
22,977 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2012-01-06 |
4 |
OE |
$59.82 |
$777,181 |
D/D |
12,992 |
20,802 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2015-03-19 |
4 |
AS |
$436.14 |
$1,017,508 |
D/D |
(2,333) |
11,310 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2012-01-06 |
4 |
AS |
$116.00 |
$1,507,072 |
D/D |
(12,992) |
9,135 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2015-03-09 |
4 |
AS |
$417.23 |
$1,946,795 |
D/D |
(4,666) |
11,310 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2015-03-17 |
4 |
AS |
$425.45 |
$1,985,589 |
D/D |
(4,667) |
11,310 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2015-03-20 |
4 |
AS |
$475.00 |
$5,541,825 |
D/D |
(11,667) |
11,310 |
0 |
- |
|
68 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|